Make a difference, and make it soon. Come join a highly motivated and focused team and help us move forward.

About Zikani Therapeutics

Zikani Therapeutics is using its innovative chemistry technology platform to develop novel Ribosome Targeting Molecules. We are focused on developing and commercializing therapeutics for patients with limited treatment options.

At Zikani, we start with a rational approach to designing Ribosome Targeting Molecules (RTMs), that expands the structural diversity of these molecules. Our goal is to develop breakthrough RTMs that are orally delivered, safe and potent for the most difficult diseases.

Make a difference and, Make it Soon

OUR SCIENCE

Our Approach to Ribosome targeted drugs

Many drug classes are known to bind to all or part of the ribosome. However, many of these drugs have safety, efficacy or delivery liabilities that have prevented their full potential to be tapped

At Zikani, we start with a rational approach to designing Ribosome Targeting Molecules (RTMs), that expands the structural diversity of these molecules. Our goal is to develop breakthrough RTMs that are orally delivered, safe and potent for the most difficult diseases.

Leadership

At Zikani Therapeutics, We have a team of experts on bringing on their years of experience on developing and commercializing therapies. Our team is dedicated to improve the life of patients by developing Novel Ribosome Targeting Molecules

Let’s work together

At Zikani Therapeutics, we are eager to collaborate with academic institutions and other companies who are interested in the development of Ribosome Targeting Molecules with a focus on treating patients that have currently limited options. We believe that collaborative alliances are the most effective way to develop new medicines. If you would like to discuss working together, we’d be delighted to speak with you.